» Articles » PMID: 26675679

GluN2D N-Methyl-d-Aspartate Receptor Subunit Contribution to the Stimulation of Brain Activity and Gamma Oscillations by Ketamine: Implications for Schizophrenia

Overview
Specialty Pharmacology
Date 2015 Dec 18
PMID 26675679
Citations 36
Authors
Affiliations
Soon will be listed here.
Abstract

The dissociative anesthetic ketamine elicits symptoms of schizophrenia at subanesthetic doses by blocking N-methyl-d-aspartate receptors (NMDARs). This property led to a variety of studies resulting in the now well-supported theory that hypofunction of NMDARs is responsible for many of the symptoms of schizophrenia. However, the roles played by specific NMDAR subunits in different symptom components are unknown. To evaluate the potential contribution of GluN2D NMDAR subunits to antagonist-induced cortical activation and schizophrenia symptoms, we determined the ability of ketamine to alter regional brain activity and gamma frequency band neuronal oscillations in wild-type (WT) and GluN2D-knockout (GluN2D-KO) mice. In WT mice, ketamine (30 mg/kg, i.p.) significantly increased [(14)C]-2-deoxyglucose ([(14)C]-2DG) uptake in the medial prefrontal cortex (mPFC), entorhinal cortex and other brain regions, and decreased activity in the somatosensory cortex and inferior colliculus. In GluN2D-KO mice, however, ketamine did not significantly increase [(14)C]-2DG uptake in any brain region examined, yet still decreased [(14)C]-2DG uptake in the somatosensory cortex and inferior colliculus. Ketamine also increased locomotor activity in WT mice but not in GluN2D-KO mice. In electrocorticographic analysis, ketamine induced a 111% ± 16% increase in cortical gamma-band oscillatory power in WT mice, but only a 15% ± 12% increase in GluN2D-KO mice. Consistent with GluN2D involvement in schizophrenia-related neurologic changes, GluN2D-KO mice displayed impaired spatial memory acquisition and reduced parvalbumin (PV)-immunopositive staining compared with control mice. These results suggest a critical role of GluN2D-containing NMDARs in neuronal oscillations and ketamine's psychotomimetic, dissociative effects and hence suggests a critical role for GluN2D subunits in cognition and perception.

Citing Articles

Therapeutic Study of Cinnamic Acid Derivative for Oxidative Stress Ablation: The Computational and Experimental Answers.

Ojo O, Ogunlakin A, Maimako R, Gyebi G, Olowosoke C, Taiwo O Molecules. 2023; 28(21).

PMID: 37959844 PMC: 10648207. DOI: 10.3390/molecules28217425.


Understanding the role of the NMDA receptor subunit, GluN2D, in mediating NMDA receptor antagonist-induced behavioral disruptions in male and female mice.

Vinnakota C, Schroeder A, Du X, Ikeda K, Ide S, Mishina M J Neurosci Res. 2023; 102(1):e25257.

PMID: 37814998 PMC: 10953441. DOI: 10.1002/jnr.25257.


Potential Roles for the GluN2D NMDA Receptor Subunit in Schizophrenia.

Vinnakota C, Hudson M, Jones N, Sundram S, Hill R Int J Mol Sci. 2023; 24(14).

PMID: 37511595 PMC: 10380280. DOI: 10.3390/ijms241411835.


Additional Depth to the NMDA Receptor Hypofunction and Parvalbumin Cell Dysfunction Hypotheses of Schizophrenia.

Camp C, Traynelis S Biol Psychiatry. 2023; 94(4):283-284.

PMID: 37495331 PMC: 10648280. DOI: 10.1016/j.biopsych.2023.06.007.


The role of ketamine in major depressive disorders: Effects on parvalbumin-positive interneurons in hippocampus.

Barrutieta-Arberas I, Ortuzar N, Vaquero-Rodriguez A, Pico-Gallardo M, Bengoetxea H, Guevara M Exp Biol Med (Maywood). 2023; 248(7):588-595.

PMID: 37158084 PMC: 10350797. DOI: 10.1177/15353702231170007.


References
1.
Gonzalez-Burgos G, Lewis D . GABA neurons and the mechanisms of network oscillations: implications for understanding cortical dysfunction in schizophrenia. Schizophr Bull. 2008; 34(5):944-61. PMC: 2518635. DOI: 10.1093/schbul/sbn070. View

2.
Kotermanski S, Johnson J . Mg2+ imparts NMDA receptor subtype selectivity to the Alzheimer's drug memantine. J Neurosci. 2009; 29(9):2774-9. PMC: 2679254. DOI: 10.1523/JNEUROSCI.3703-08.2009. View

3.
Hunt M, Olszewski M, Piasecka J, Whittington M, Kasicki S . Effects of NMDA receptor antagonists and antipsychotics on high frequency oscillations recorded in the nucleus accumbens of freely moving mice. Psychopharmacology (Berl). 2015; 232(24):4525-35. PMC: 4646921. DOI: 10.1007/s00213-015-4073-0. View

4.
Ikeda K, Nagasawa M, Mori H, Araki K, Sakimura K, Watanabe M . Cloning and expression of the epsilon 4 subunit of the NMDA receptor channel. FEBS Lett. 1992; 313(1):34-8. DOI: 10.1016/0014-5793(92)81178-o. View

5.
Miyamoto S, Leipzig J, Lieberman J, Duncan G . Effects of ketamine, MK-801, and amphetamine on regional brain 2-deoxyglucose uptake in freely moving mice. Neuropsychopharmacology. 2000; 22(4):400-12. DOI: 10.1016/S0893-133X(99)00127-X. View